BOS
Bingham Osborn & Scarborough Portfolio holdings
AUM
$1.42B
1-Year Est. Return
27.88%
1 Year Est. Return
+27.88%
AUM
$1.42B
AUM Growth
+$6.18M
(+0.44%)
Holding
170
Top Buys
| 1 | +$16.7M | |
| 2 | +$7.69M | |
| 3 | +$3.41M | |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$2.76M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.26M |
Top Sells
| 1 | +$7.33M | |
| 2 | +$4.94M | |
| 3 | +$2.14M | |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.57M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.16M |
Sector Composition
| 1 | Technology | 2.22% |
| 2 | Consumer Discretionary | 1.19% |
| 3 | Industrials | 0.98% |
| 4 | Healthcare | 0.91% |
| 5 | Financials | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Mercado Libre
MELI
$117B
| $212K | 0.01% |
+126
|
|
||
152
American Tower
AMT
$82.7B
| $210K | 0.01% |
790
+48
|
|
||
153
Curtiss-Wright
CW
$22.7B
| $210K | 0.01% |
+1,668
|
|
||
154
Protagonist Therapeutics
PTGX
$4.72B
| $206K | 0.01% |
11,640
|
|
||
155
Intuit
INTU
$189B
| $202K | 0.01% |
+375
|
|
||
156
Gilead Sciences
GILD
$152B
| $200K | 0.01% |
+2,864
|
|
||
157
Gerdau
GGB
$6.91B
| $58K | ﹤0.01% |
+14,751
|
|
||
158
Alibaba
BABA
$400B
| – | – |
-1,187
|
|
||
159
CVS Health
CVS
$99.6B
| – | – |
-3,570
|
|
||
160
GoDaddy
GDDY
$18.2B
| – | – |
-2,529
|
|
||
161
GE Aerospace
GE
$326B
| – | – |
-2,951
|
|
||
162
Goldman Sachs
GS
$243B
| – | – |
-674
|
|
||
163
iShares Global Clean Energy ETF
ICLN
$1.91B
| – | – |
-8,982
|
|
||
164
Illinois Tool Works
ITW
$70.5B
| – | – |
-1,106
|
|
||
165
Nike
NKE
$92.6B
| – | – |
-1,402
|
|
||
166
Norfolk Southern
NSC
$63.3B
| – | – |
-896
|
|
||
167
Tucows
TCX
$209M
| – | – |
-3,500
|
|
||
168
Wells Fargo
WFC
$274B
| – | – |
-9,760
|
|
||
|
MMP
169
DELISTED
Magellan Midstream Partners, L.P.
MMP
| – | – |
-4,900
|
|
||
|
FMBI
170
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| – | – |
-15,396
|
|